74 results on '"Fu, Ziyi"'
Search Results
2. The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation.
- Author
-
Wang, Zhen-Zhen, Li, Hang, Maskey, Anish R, Srivastava, Kamal, Liu, Changda, Yang, Nan, Xie, Taoyun, Fu, Ziyi, Li, Junxiong, Liu, Xiaohong, Sampson, Hugh A, and Li, Xiu-Min
- Subjects
INFLAMMATION ,MEDICAL botany ,HEMATOXYLIN & eosin staining ,REACTIVE oxygen species ,ANTIASTHMATIC agents - Abstract
Objective of this study is to investigate GAC1 effect on neutrophil-dominant, steroid-resistant asthma in a murine model. Methods: In this study, Balb/c mice were systematically sensitized with ragweed (RW) and alum and intranasally challenged with ragweed. Unsensitized/PBS challenged mice served as normal controls. Post sensitization, mice were given 4 weeks of oral treatment with GAC1 or acute dexamethasone (Dex) treatment at 48 hours prior to challenge. Pulmonary cytokines were measured by ELISA, and lung sections were processed for histology by H&E staining. Furthermore, GAC1 effect on MUC5AC expression and on reactive oxygen species (ROS) production in human lung epithelial cell line (NCI-H292) was determined by qRT-PCR and ROS assay kit, respectively. Computational analysis was applied to select potential targets of GAC1 in steroid-resistant neutrophil-dominant asthma. Molecular docking was performed to predict binding modes between GAC1 and Dex with TNF-α. Results: The result of the study showed that chronic GAC1 treatment, significantly reduced pulmonary inflammation (P < 0.01– 0.001 vs Sham) and airway neutrophilia (P < 0.01 vs Sham), inhibited TNF-α, IL-4 and IL-5 levels (P < 0.05– 0.001 vs Sham). Acute Dex treatment reduced eosinophilic inflammation and IL-4, IL-5 levels, but had no effect on neutrophilia and TNF-α production. GAC1 treated H292 cells showed decreased MUC5AC gene expression and production of ROS (P < 0.001 vs stimulated/untreated cells). Molecular docking results showed binding energy of complex GAC1-TNF was − 10.8 kcal/mol. Discussion: GAC1 may be a promising anti-asthma botanical drug for treatment of steroid-resistant asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Giant enhancement of second harmonic generation via merging bound states in the continuum for vacuum ultraviolet radiation.
- Author
-
Li, Jianmei, Chang, Wenyao, Guo, Zirui, Li, Pinxu, Fu, Ziyi, Luo, Cai, Hou, Yanxue, Guo, Yang, and Gu, Changzhi
- Subjects
SECOND harmonic generation ,BOUND states ,FAR ultraviolet radiation ,COHERENT radiation ,PHOTONIC crystals ,NANOLITHOGRAPHY - Abstract
Vacuum ultraviolet (VUV) light plays a crucial role in various scientific and technological fields, such as nanolithography and biomedical treatments. However, the inherent nonlinear optical coefficient of nonlinear optical crystals is typically very low, and increasing the action length is often necessary to improve the nonlinear conversion efficiency. This makes it challenging for these materials to achieve high-density optoelectronic integration at the micro-/nano-scale. In this study, we propose a design for generating coherent VUV radiation close to 175 nm using second harmonic generation (SHG) with an absolute efficiency exceeding 1.2‰ mW
−1 . This is achieved by merging multiple bound state in the continuum modes in a free-standing photonic crystal slab. Even with fabrication imperfections at a level lower than 10% disorder, the SHG efficiency of the samples remains robust, maintaining an efficiency of at least 2‰. This research provides a beneficial platform for generating efficient VUV light in the nanoscale. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
4. An Imbalance in Histone Modifiers Induces tRNA-Cys-GCA Overexpression and tRF-27 Accumulation by Attenuating Promoter H3K27me3 in Primary Trastuzumab-Resistant Breast Cancer.
- Author
-
Duan, Ningjun, Hua, Yijia, Yan, Xueqi, He, Yaozhou, Zeng, Tianyu, Gong, Jue, Fu, Ziyi, Li, Wei, and Yin, Yongmei
- Subjects
RNA physiology ,PROTEINS ,DRUG resistance in cancer cells ,TRASTUZUMAB ,RESEARCH funding ,BREAST tumors ,CELL physiology ,TRANSCRIPTION factors ,HISTONES ,GENE expression ,MOLECULAR structure - Abstract
Simple Summary: tRF-27 has been identified as upregulated in both naïve trastuzumab-resistant HER2-positive breast cancer cells and patient samples, positioning it as a potential biomarker. However, the underlying mechanisms of this upregulation remain unclear. This study proposes that the abnormal transcription of specific tRNA-Cys-GCA isodecoders in naïve trastuzumab-resistant cells might contribute to the accumulation of tRF-27. Additionally, the reduction in H3K27me3 modifications at these tRNA genes, attributed to imbalances in histone modification enzymes, appears to influence tRNA transcription alterations. Building upon these findings, our research demonstrates that the application of a demethylase inhibitor may offer a potential strategy to overcome trastuzumab resistance. tRNA-derived fragments (tRFs) play crucial roles in cancer progression. Among them, tRF-27 has been identified as a key factor in promoting naïve trastuzumab resistance in HER2-positive breast cancer. However, the origin of tRF-27 remains uncertain. In this study, we propose that the upregulated expression of specific cysteine tRNAs may lead to the increased accumulation of tRF-27 in trastuzumab-resistant JIMT1 cells. Mechanistically, the reduced inhibitory H3K27me3 modification at the promoter regions of tRF-27-related tRNA genes in JIMT1 cells, potentially resulting from decreased EZH2 and increased KDM6A activity, may be a critical factor stimulating the transcriptional activity of these tRNA genes. Our research offers fresh insights into the mechanisms underlying elevated tRF-27 levels in trastuzumab-resistant breast cancer cells and suggests potential strategies to mitigate trastuzumab resistance in clinical treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in triple-negative breast cancer.
- Author
-
Mei, Jie, Cai, Yun, Zhu, Hongjun, Jiang, Ying, Fu, Ziyi, Xu, Junying, Chen, Lingyan, Yang, Kai, Zhao, Jinlu, Song, Chenghu, Zhang, Yan, Mao, Wenjun, and Yin, Yongmei
- Published
- 2024
- Full Text
- View/download PDF
6. Molecular dynamics simulation of the distribution of potassium perfluorooctanesulfonate in water.
- Author
-
Jing, Xianwu, Zhou, Lang, Li, Shengtao, Xu, Yuan, Liu, Qiang, and Fu, Ziyi
- Abstract
We used the molecular dynamics method to simulate the behavior of potassium perfluorohexanesulfonate (KPFOS) in water/gas system. The results indicate that PFOS
− can spontaneously migrate to the water/gas interface and form a layered structure with hydrophobic tail chains facing the gas phase and hydrophilic sulfonic acid groups immersed in the water phase, while some PFOS− molecules within the solution formed spherical micelles. Both the number density and charge density distributions confirm that PFOS− and K+ are mainly distributed at the water/gas interface, and a small amount of PFOS− and K+ are distributed in the bulk solution. Based on the results of radial distribution function, the probability of K+ appearing near oxygen atoms in PFOS− is very high due to electrostatic attraction. Based on the IGMH analysis, the oxygen atoms in PFOS− can form multiple hydrogen bonds with adjacent water molecules, while there is only weak van der Waals interaction between K+ and water molecules. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
7. Molecular simulation of imperfect structure I CO2 hydrate growth in brine.
- Author
-
Fu, Ziyi, Jing, Xianwu, Zhou, Li, Luo, Qin, and Zhang, Pengfei
- Subjects
SALINE waters ,SALT ,MOLECULAR dynamics ,CARBON dioxide ,HYDROGEN bonding - Abstract
In order to investigate the viability of carbon dioxide (CO2) storage in seawater, molecular dynamics techniques were employed to study the dynamic evolution of CO2 hydrate in saline water. The simulation was conducted under specific conditions: a temperature of 275 K, a pressure of 10 MPa and a simulated marine environment achieved using a 3.4 wt% sodium chloride (NaCl) solution. The total simulation time was 1000 ns. The results of the simulation indicate that the pre‐existence of CO2 hydrate crystals as seeds leads to rapid growth of CO2 hydrate. However, analysis of the F3 and F4 order parameters reveals that the hydrate does not meet the standard values of the perfect structure I (sI) type, confirming the existence of an imperfect structure during the simulation. Additionally, the changes in the number of different phase states of water molecules during the hydrate growth process shows that there are always some liquid water molecules, which means some water molecules fail to form solid water cages. Further investigation suggests that the presence of Na+ and Cl− hampers the hydrogen bonds between water molecules, resulting in incomplete cage structures. By analyzing the density variations in the system, it is observed that CO2 hydrate, with a density of around 1.133 g cm−3, forms rapidly, surpassing the average density of seawater. This density increase facilitates the efficient and swift containment of CO2 on the seabed, thereby supporting the feasibility of the CO2 storage theory. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer: A randomized, double‐blind, phase III study.
- Author
-
Chen, Likun, Rangel, Jose David Gomez, Cil, Timucin, Li, Xingya, Cicin, Irfan, Shen, Yihong, Liu, Zhihua, Ozyilkan, Ozgur, Igor, Bondarenko, Chen, Jun, Oleksandr, Kostiuk, Chen, Zhendong, Zhang, Helong, Fu, Ziyi, Dong, Qingfeng, Song, Shuqiang, Yu, Jin‐Chen, Zhang, Li, Hryhoriy, Adamchuk, and Karaoglu, Aziz
- Subjects
NON-small-cell lung carcinoma ,BEVACIZUMAB - Abstract
Background: BAT1706 is a proposed biosimilar of bevacizumab (Avastin®). We aimed to compare the efficacy and safety of BAT1706 with that of EU‐sourced reference bevacizumab (EU‐bevacizumab) in patients with advanced nonsquamous non‐small cell lung cancer (NSCLC). Methods: Patients were randomized 1:1 to BAT1706 plus paclitaxel and carboplatin (BAT1706 arm) or EU‐bevacizumab plus paclitaxel and carboplatin (EU‐bevacizumab arm) given every 3 weeks for six cycles, followed by maintenance therapy with BAT1706 or EU‐bevacizumab. The primary endpoint was overall response rate at week 18 (ORR18). Clinical equivalence was demonstrated if the 90% confidence interval (CI) of the BAT1706:EU‐bevacizumab ORR18 risk ratio was contained within the predefined equivalence margins of 0.75–1.33 (China National Medical Products Administration requirements), or 0.73–1.36 (US Food and Drug Administration), or if the 95% CI of the ORR18 risk difference between treatments was contained within the predefined equivalence margin of −0.12 to 0.15 (EMA requirements). Results: In total, 649 randomized patients (BAT1706, n = 325; EU‐bevacizumab, n = 324) received at least one cycle of combination treatment. The ORR18 was comparable between the BAT1706 and EU‐bevacizumab arms (48.0% and 44.5%, respectively). The ORR18 risk ratio of 1.08 (90% CI: 0.94–1.24) and the ORR18 risk difference of 0.03 (95% CI: −0.04 to 0.11) were within the predefined equivalence margins, demonstrating the biosimilarity of BAT1706 and EU‐bevacizumab. The safety profile of BAT1706 was consistent with that of EU‐bevacizumab and no new safety signals were observed. Conclusion: In patients with advanced nonsquamous NSCLC, BAT1706 demonstrated clinical equivalence to EU‐bevacizumab in terms of efficacy, safety, pharmacokinetics, and immunogenicity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer.
- Author
-
Zhang, Yanchao, Zhao, Guomeng, Yu, Liting, Wang, Xindong, Meng, Yao, Mao, Jinlei, Fu, Ziyi, Yin, Yongmei, Li, Jinyao, Wang, Xun, and Guo, Changying
- Abstract
Background: NME1 has been exploited as a potential translational target for decades. Substantial efforts have been made to upregulate the expression of NME1 and restore its anti-metastasis function in metastatic cancer. Methods: Cycloheximide (CHX) chase assay was used to measure the steady-state protein stability of NME1 and HSP90α. The NME1-associating proteins were identified by immunoprecipitation combined with mass spectrometric analysis. Gene knockdown and overexpression were employed to examine the impact of HSP90AA1 on intracellular NME1 degradation. The motility and invasiveness of breast cancer cells were examined in vitro using wound healing and transwell invasion assays. The orthotopic spontaneous metastasis and intra-venous experimental metastasis assays were used to test the formation of metastasis in vivo, respectively. Results: HSP90α interacts with NME1 and increases NME1 lifetime by impeding its ubiquitin-proteasome-mediated degradation. HSP90α overexpression significantly inhibits the metastatic potential of breast cancer cells in vitro and in vivo. A novel cell-permeable peptide, OPT22 successfully mimics the HSP90α function and prolongs the life span of endogenous NME1, resulting in reduced metastasis of breast cancer. Conclusion: These results not only reveal a new mechanism of NME1 degradation but also pave the way for the development of new and effective approaches to metastatic cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4.
- Author
-
Zhang, Meng, Wang, Mei, Jiang, Zhiming, Fu, Ziyi, Ma, Jingjing, and Gao, Sheng
- Subjects
REVERSE transcriptase polymerase chain reaction ,BIOCHEMISTRY ,WESTERN immunoblotting ,PHENOMENOLOGICAL biology ,MICRORNA ,GENE expression ,CELL proliferation ,DESCRIPTIVE statistics ,RESEARCH funding ,TAMOXIFEN ,HISTONE deacetylase ,CELL lines ,HORMONE receptor positive breast cancer ,DRUG resistance in cancer cells - Abstract
Tamoxifen is a drug used for treating breast cancer (BC), especially for individuals diagnosed with estrogen receptor-positive (ER+) BC. Its prolonged use could reduce the risk of recurrence and significantly lengthen the survival rate of BC patients. However, an increasing number of patients developed resistance to tamoxifen treatment, which reduced therapeutic efficiency and caused substandard prognosis. Therefore, the exploration of the molecular processes involved in tamoxifen resistance (TR) is urgently required. This investigation aimed to elucidate the relationship of microRNA-330 (miR-330-3p) with the TR of BC. There is little information on miR-330-3p′s link with drug-resistant BC, although it is well known to regulate cell proliferation and apoptosis. Primarily, miR-330-3p expression in parental BC (MCF7/T47D), TR (MCF7-TR), and T47D/TR cell lines was detected by qRT-PCR. Then, the impact of miR-330-3p on the TR of BC cells was assessed by a cell proliferation assay. Lastly, dual-luciferase reporter, qRT-PCR, and western blot assessments were carried out to identify histone deacetylase 4 (HDAC4) as the potential miR-330-3p target gene. The data indicated that miRNA-330 was overexpressed in TR ER+ BC cells and its overexpression could induce TR. Furthermore, miRNA-330 could also reduce the expression of HDAC4, which is closely linked to TR, and overexpression of HDAC4 could reverse miRNA-330-induced drug resistance. In summary, miR-330-3p could induce TR of ER+ BC cells by downregulating HDAC4 expression, which might be a novel marker of TR and a possible treatment target against BC patients who are tamoxifen-resistant. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop.
- Author
-
Yang, Qingbin, Lei, Xuetao, He, Jiayong, Peng, Yanmei, Zhang, Yihao, Ling, Ruoyu, Wu, Chaorui, Zhang, Guofan, Zheng, Boyang, Chen, Xinhua, Zou, Boya, Fu, Ziyi, Zhao, Liying, Liu, Hao, Hu, Yanfeng, Yu, Jiang, Li, Fengping, Ye, Gengtai, and Li, Guoxin
- Subjects
STOMACH cancer ,NEOVASCULARIZATION inhibitors ,GLYCOLYSIS ,ADDICTIONS ,GLUCOSE metabolism ,APATINIB ,ENDOSTATIN - Abstract
Anti‐angiogenic therapy has long been considered a promising strategy for solid cancers. Intrinsic resistance to hypoxia is a major cause for the failure of anti‐angiogenic therapy, but the underlying mechanism remains unclear. Here, it is revealed that N4‐acetylcytidine (ac4C), a newly identified mRNA modification, enhances hypoxia tolerance in gastric cancer (GC) cells by promoting glycolysis addiction. Specifically, acetyltransferase NAT10 transcription is regulated by HIF‐1α, a key transcription factor of the cellular response to hypoxia. Further, acRIP‐sequencing, Ribosome profiling sequencing, RNA‐sequencing, and functional studies confirm that NAT10 in turn activates the HIF‐1 pathway and subsequent glucose metabolism reprogramming by mediating SEPT9 mRNA ac4C modification. The formation of the NAT10/SEPT9/HIF‐1α positive feedback loop leads to excessive activation of the HIF‐1 pathway and induces glycolysis addiction. Combined anti‐angiogenesis and ac4C inhibition attenuate hypoxia tolerance and inhibit tumor progression in vivo. This study highlights the critical roles of ac4C in the regulation of glycolysis addiction and proposes a promising strategy to overcome resistance to anti‐angiogenic therapy by combining apatinib with ac4C inhibition. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. The Location Optimization of Urban Shared New Energy Vehicles Based on P-Median Model: The Example of Xuzhou City, China.
- Author
-
Dang, Jianmin, Wang, Xiaozhen, Xie, Ying, and Fu, Ziyi
- Abstract
Sharing new energy vehicles is crucial for addressing the issue of traditional vehicles' carbon emissions, reducing urban traffic congestion, safeguarding the environment, and promoting citizens' use of green transportation. However, the parking lot's drawbacks—poor location, challenging parking, and difficulty finding a car—lead to a low popularity rate, few users, and infrequent use. How to scientifically choose parking outlets and maximize the advantages of sharing new energy vehicles has become an important topic in current urban traffic management. This paper constructed a "G-B-U" framework starting with quasi-public goods and stakeholders to analyze the factors influencing the location selection of these vehicles. On this basis, a three-stage location decision method of "market demand prediction—alternative network screening—location model solution" is proposed to optimize the location selection of shared new energy vehicles. The factors are analyzed, and numerical examples are studied, using the districts of Xuzhou City in China as examples: Gulou, Yunlong, and Quanshan. The findings indicate that the main variables influencing how frequently Xuzhou residents use shared new energy cars are network dispersion, rental and return convenience, and usage experience. After site selection optimization, the journey distance is nearly cut in half, saving users a significant amount of travel time. It may meet the travel needs of residents better based on the same number of parking lots. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. An implementation of complex-valued matrix-vector multiplication based on MZI array for photonic neural networks.
- Author
-
Zhao, Zichao, Chen, Bei, Fu, Ziyi, Yu, Zeye, Li, Maohui, Wang, Yuehai, and Yang, Jianyi
- Published
- 2024
- Full Text
- View/download PDF
14. Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast Cancer.
- Author
-
Sun, Chunxiao, Huang, Xiang, Li, Jun, Fu, Ziyi, Hua, Yijia, Zeng, Tianyu, He, Yaozhou, Duan, Ningjun, Yang, Fan, Liang, Yan, Wu, Hao, Li, Wei, Zhang, Yuchen, and Yin, Yongmei
- Subjects
NUCLEOTIDE metabolism ,EXOSOMES ,TRANSFER RNA ,APOPTOSIS ,GENE expression ,TUMOR necrosis factors ,RESEARCH funding ,TAMOXIFEN ,PROGRESSION-free survival ,EXTRACELLULAR space ,CELL lines ,DRUG resistance in cancer cells ,BREAST tumors ,CASPASES ,PHARMACODYNAMICS - Abstract
Simple Summary: While the prognosis of hormone receptor-positive (HR+) breast cancer has been significantly improved, tamoxifen resistance remains a challenge in the treatment of HR+ breast cancer. This study identified that tRF-16-K8J7K1B, a novel small ncRNA derived from the 3′-end of tRNA
Ala-TGC , was highly expressed in tamoxifen-resistant cells compared to parental cells. Moreover, extracellular tRF-16-K8J7K1B confers tamoxifen resistance via incorporation into exosomes and then degrades the expression of apoptosis-related proteins, reducing the proportion of drug-induced cell apoptosis. Therefore, we propose that exosomal tRF-16-K8J7K1B could be a potential predictive biomarker and therapeutic target for overcoming tamoxifen resistance. Tamoxifen resistance remains a challenge in hormone receptor-positive (HR+) breast cancer. Recent evidence suggests that transfer ribonucleic acid (tRNA)-derived fragments play pivotal roles in the occurrence and development of various tumors. However, the relationship between tRNA-derived fragments and tamoxifen resistance remains unclear. In this study, we found that the expression of tRF-16-K8J7K1B was upregulated in tamoxifen-resistant cells in comparison with tamoxifen-sensitive cells. Higher levels of tRF-16-K8J7K1B were associated with shorter disease-free survival in HR+ breast cancer. Overexpression of tRF-16-K8J7K1B promotes tamoxifen resistance. Moreover, extracellular tRF-16-K8J7K1B could be packaged into exosomes and could disseminate tamoxifen resistance to recipient cells. Mechanistically, exosomal tRF-16-K8J7K1B downregulates the expression of apoptosis-related proteins, such as caspase 3 and poly (ADP-ribose) polymerase, by targeting tumor necrosis factor-related apoptosis-inducing ligand in receptor cells, thereby reducing drug-induced cell apoptosis. Therapeutically, the inhibition of exosomal tRF-16-K8J7K1B increases the sensitivity of breast cancer cells to tamoxifen in vivo. These data demonstrate that exosomal tRF-16-K8J7K1B may be a novel therapeutic target to overcome tamoxifen resistance in HR+ breast cancer. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
15. Maternal Serum tRNA-Derived Fragments (tRFs) as Potential Candidates for Diagnosis of Fetal Congenital Heart Disease.
- Author
-
Lu, Enkang, Wu, Lijun, Chen, Bin, Xu, Shipeng, Fu, Ziyi, Wu, Yun, Wu, Yanhu, and Gu, Haitao
- Published
- 2023
- Full Text
- View/download PDF
16. Effect of anionic surfactant on the properties of nonionic hydrophobically associating polymer based slick water.
- Author
-
Jing, Xianwu, Fu, Ziyi, and Liu, Youquan
- Subjects
SODIUM dodecyl sulfate ,NONIONIC surfactants ,ANIONIC surfactants ,DRAG reduction ,DRAG (Aerodynamics) ,TRITON X-100 ,POLYMERS - Abstract
A water-soluble nonionic surfactant hydrophobic monomer (AT100) was synthesized by esterification of acryloyl chloride with Triton X-100, after that, a nonionic hydrophobically associating polyacrylamide P(AM-AT100) was synthesized and used as drag reducer. They were characterized by IR and NMR. In fresh water, when the concentration of drag reducer reached 0.3 g·L
−1 (so called slick water), the viscosity was 3.86 mm2 ·s−1 with a drag reduction rate up to 74.7%. After sodium dodecyl sulfate (SDS) was added into the slick water, hydrophobic chains of SDS and hydrophobic units in P(AM-AT100) aggregated and micelles were likely formed, and this process was just like hydrophobic association. The viscosity of the slick water increased significantly, while the drag reduction rate of the mixed system decreased. With SDS concentration at 1.5 g·L−1 and the drag reducer concentration at 0.3 g·L−1 , the drag reduction rate was 71.72% and viscosity was 6.25 mm2 ·s−1 , indicating that increasing viscosity had a significantly adverse effect on drag reduction performance. The proppant layup experiment confirmed that the sand-carrying capacity of low-viscosity slick water is limited, so proppant will settle inevitably. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
17. A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.
- Author
-
Zeng, Tianyu, Sun, Chunxiao, Liang, Yan, Yang, Fan, Yan, Xueqi, Bao, Shengnan, Zhang, Yucheng, Huang, Xiang, Fu, Ziyi, Li, Wei, and Yin, Yongmei
- Subjects
RESEARCH ,GENETIC mutation ,EPIDERMAL growth factor receptors ,ONCOGENES ,ORAL drug administration ,METASTASIS ,TREATMENT duration ,RETROSPECTIVE studies ,PROTEIN-tyrosine kinase inhibitors ,DESCRIPTIVE statistics ,TUMOR markers ,BREAST tumors ,PHARMACODYNAMICS - Abstract
Simple Summary: There are limited treatments for patients with HER2-negative breast cancer, especially for patients with metastatic breast cancer. This study aimed to observe the efficacy and safety of low-dose apatinib combined with chemotherapy in real-world clinical diagnosis and treatment of HER2-negative metastatic breast cancer. A total of 128 patients were treated with 250 mg apatinib, and we observed the median progression-free survival (PFS) and overall survival (OS) were 4.7 months and 15.3 months, respectively. This observation also indicated that the breast cancer susceptibility gene (BRCA) mutation predicted a better response to apatinib and that combination of immunotherapy or paclitaxel-platinum regimens might be an optimal treatment option. Importantly, a lower dose of apatinib showed mild side effects that improved the patients' life quality. Treatment options for human epidermal growth factor receptor (HER2)-negative breast cancer patients are limited in comparison to the HER2-positive patients, particularly for metastatic breast cancer patients. Apatinib is a small-molecule tyrosine kinase inhibitor that targets the vascular endothelial growth factor receptor 2 (VEGFR-2). Here, we reported the apatinib-based therapy data in HER2-negative metastatic breast cancer. Apatinib was taken at a dose of 250 mg orally once per day and combined with standard chemotherapy regimens. The PFS and OS of 128 patients were 4.7 months and 15.3 months, respectively. The objective response rate (ORR) and the disease control rate (DCR) were 22.7% and 80.5%, respectively. Patients with breast cancer susceptibility gene (BRCA) mutations were found to have a longer PFS and OS. Moreover, combination immunotherapy or paclitaxel-platinum regimens shared an improved response to other regimens. Most of the adverse effects (hypertension, anaemia, and hand-foot syndrome) were grade 1 to 2. Metastatic breast cancer patients could benefit from apatinib therapy at a low dosage, and the adverse effects are mild in real-world clinical practice. Furthermore, BRCA may be a putative biomarker for apatinib in HER2-negative breast cancer. Immunotherapy or paclitaxel-platinum regimens may be recommended to combine with apatinib therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Identification of microRNA expression profiles of CD44+ ovarian cancer stem cells.
- Author
-
Wang, Luyao, Zhi, Xiaogai, Lu, Yingying, Cong, Yu, Fu, Ziyi, Cao, Jian, Xu, Sujuan, Lv, Juan, and Ruan, Hongjie
- Abstract
Purpose: The aim of our study was to investigate microRNA (miRNA) expression profiles in CD44
+ ovarian cancer stem cells (ovarian CSCs). Methods: In this study, we enriched CD44+ ovarian CSCs using magnetic activated cell sorting (MACS). A combination of real-time quantitative PCR (qRT-PCR), western blot and sphere formation assays was used to demonstrate stem cell-like properties. RNA sequencing was used to detect the miRNA expression profiles in CD44+ ovarian CSCs. Transient transfection, qRT-PCR, western blot and sphere formation assays were further used to test the function of miR-181a-2-3p. Results: We found that CD44+ ovarian CSCs showed enhanced sphere formation and expression of stemness-associated genes (NANOG, OCT4, SOX2) compared to ovarian cancer cells. The RNA sequencing results showed that the miRNA expression profiles of CD44+ ovarian CSCs were different from those of ovarian cancer cells. GO and KEGG pathway analyses indicated that these miRNAs regulate stem cell-like properties in CD44+ ovarian CSCs. In addition, miR-181a-2-3p negatively regulates the stem cell-like properties of CD44+ ovarian CSCs by targeting EGR1. Conclusion: Our data suggest that miRNAs play important roles in regulating the stem cell-like properties of CD44+ ovarian CSCs. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
19. Molecular Dynamics Simulation of CO2 Hydrate Growth and Intermolecular Weak Interaction Analysis.
- Author
-
Jing, Xianwu, Chen, Lili, Liu, Youquan, and Fu, Ziyi
- Subjects
MOLECULAR dynamics ,INTERMOLECULAR interactions ,CARBON dioxide ,AQUEOUS solutions ,HYDROGEN bonding - Abstract
The growth of carbon dioxide (CO
2 ) hydrate in CO2 aqueous solution (box A), and in CO2 aqueous solution with structure I (sI) CO2 hydrate cell as seed (box B) under the same conditions of 275 K and 10 MPa, were simulated respectively. The total simulation time is 5000 ns. The nucleation process is very slow, so it is difficult to observe CO2 hydrate growth in box A without CO2 hydrate seed, CO2 just accumulates to form bubbles, while H2 O still remains liquid, the F4 order parameter remains about –0.1. By contrast, beautiful CO2 hydrate in box B grows rapidly, CO2 is trapped in the cages formed by H2 O molecules, F4 rises from 0.12 to 0.7 due to the formation of sI hydrate. The density of CO2 hydrate in box B is as high as 1.25 g/cm3 , higher than that of seawater, which is beneficial to its permanent sealing on the seabed. In box B, in accordance with the independent gradient model based on Hirshfeld partition (IGMH) analysis, a H2 O molecule forms four hydrogen bonds with surrounding H2 O molecules, CO2 only has van der Waals interaction with surrounding water cages. In the actual large-scale CO2 storage process, especially for the rapid storage of CO2 in the form of hydrate, it is strongly recommended to pre-add CO2 hydrate crystals into the solution to achieve the purpose of rapid growth of CO2 hydrate. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
20. A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progression.
- Author
-
Yan, Xueqi, He, Yaozhou, Yang, Shikun, Zeng, Tianyu, Hua, Yijia, Bao, Shengnan, Yang, Fan, Duan, Ningjun, Sun, Chunxiao, Liang, Yan, Fu, Ziyi, Huang, Xiang, Li, Wei, and Yin, Yongmei
- Published
- 2022
- Full Text
- View/download PDF
21. Psoralen Promotes Proliferation, Migration, and Invasion of Human Extravillous Trophoblast Derived HTR-8/Svneo Cells in vitro by NF-κB Pathway.
- Author
-
Qi, Dan, Lu, Jingyuan, Fu, Ziyi, Lv, Shanshan, and Hou, Lili
- Subjects
TROPHOBLAST ,RECURRENT miscarriage ,PSORALENS ,PREGNANCY complications ,POLYMERASE chain reaction - Abstract
Recurrent spontaneous abortion (RSA) is a kind of pathological pregnancy, and abnormal function of trophoblast cells may be related to a variety of pregnancy complications including RSA. Psoralen is an effective ingredient extracted from Cullen corylifolium (L.) Medik. with multiple bioactivities mainly including anti-osteoporotic, anti-tumor, anti-inflammatory, and estrogen-like effects. However, the exact role of psoralen on trophoblast invasiveness has not been investigated thus far. In the present study, the effects of psoralen on the proliferation, migration, and invasion abilities of HTR-8/SVneo cells were evaluated by the CCK-8 and Transwell assays. The expression patterns of nuclear factor κB (NF-κB)/p65 and metalloproteinases (MMP)-2 and MMP-9 were characterized by further experiments including real-time quantitative polymerase chain reaction and Western blot. Indirect immunofluorescence was applied to track the NF-κB p65 translocation. Herein, we found that cell viability and invasive ability were promoted by psoralen in a concentration-dependent manner. Psoralen concentration-dependently enhanced both MMP-2 and MMP-9 expression and their activity of HTR-8/SVneo cells. Additionally, we observed accelerated nuclear accumulation and enhanced nuclear translocation of p65 in the presence of psoralen. Furthermore, invasiveness enhancement of psoralen on HTR-8/SVneo cells was partly eliminated by a NF-κB pathway inhibitor. Thus, our findings suggest that psoralen may serve as a potential repurpose drug candidate that can be used to induce migration and invasion of trophoblast cells through strengthening the NF-κB pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study.
- Author
-
Bao, Shengnan, Jiang, Mengping, Wang, Xi, Hua, Yijia, Zeng, Tianyu, Yang, Yiqi, Yang, Fan, Yan, Xueqi, Sun, Chunxiao, Yang, Mengzhu, Fu, Ziyi, Huang, Xiang, Li, Jun, Wu, Hao, Li, Wei, Tang, Jinhai, and Yin, Yongmei
- Subjects
BREAST cancer ,SECONDARY primary cancer ,CANCER patients ,PROGNOSIS ,MEDICAL personnel - Abstract
Background: With life span extending, breast cancer (BC) survivors may face the possibility of developing second primary cancer (SPC) and considerably shorten survivorship. However, little is known about multiple primary cancer (MPC) patients with nonmetastatic breast cancer as a first primary malignancy (BCFPM). Methods: Here, we retrospectively analyzed data on cancer survivors with BCFPM diagnosed between 2010 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. The prognostic factors for breast cancer‐specific survival (BCSS) were ascertained by the stepwise regression analysis and a competing risk model, and were integrated to the establishment of prognostic nomogram, of which the accuracy was measured by the calibration curve and the concordance index (C‐index). Results: In total, 8616 patients were identified with 4.6% of 3‐year breast cancer‐ specific death (BCSD) and 8.6% of 5‐year BCSD. The most common SPC among BCFPM patients were female BC and lung cancer. Besides, the median latency time between BC and SPC was 22 months. At a ratio of 7:3, all patients were randomly categorized into a training cohort (n = 6032) and a validation cohort (n = 2584). By a proportional subdistribution hazards regression analysis, the following factors were considered to own independent prognostic abilities of BCSS: subtypes, grade, T classification, N classification, radiation, and sites of SPC. The nomogram could accurately predict 3‐year and 5‐year breast cancer‐associated survival of BCFPM patients with high internal and external validated C‐index, 0.715 (95% CI, 0.691–0.739), and 0.683 (95% CI, 0.642–0.724), respectively. Conclusions: BC survivors remained a high risk of developing SPC and considerably shortened survival time. In this study, a favorable nomogram was constructed to as a prediction model for 3‐year and 5‐year BCSS of BCFPM patients, largely intending to prolong the life of these patients by assisting clinicians to make individualized follow‐up plans. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Synthesis and performance evaluation of a new drag reducer–cationic hybrid polymeric based on polyacrylamide.
- Author
-
Jing, Xianwu, Huang, Chenzhi, and Fu, Ziyi
- Subjects
DRAG reduction ,POLYMERIZATION ,POLYACRYLAMIDE ,POLYMER degradation ,SCANNING electron microscopes - Abstract
The aim of the present work is to prepare polymeric materials and to be used as drag reducer. In this paper, a new type of drag reducer was synthesized with polymeric materials. Technically, N, N-dimethyl-N-hexadecyl allylammonium bromide (DHAB) was synthesized with 3-bromopropene and N, N-dimethylcetyl tertiary amine, and then cationic hydrophobically associating polyacrylamide P(AM-DHAB), the desired drag reducer, was synthesized. The chemical structures of the products were confirmed by IR and NMR. The molecular weight of the drag reducer was found to be 2.66 × 10
6 g/mol as measured by laser light scattering method. In fresh water, when the concentration of drag reducer is 0.03%, the highest drag reduction rate is reached up to 73.05%. However, when the concentration of drag reducer is further increased, the viscosity is increased and drag reduction rate is decreased; indicating high viscosity has a significant negative effect on drag reduction rate. While in brine, with a viscosity obviously lower than that in fresh water, the drag reduction rate was slightly lower than 70% when the concentration of drag reducer was 0.03%; increasing the concentration of P(AM-DHAB) did not lead to a significant increase in viscosity, instead, it caused the drag reduction rate to be higher than 70%. Therefore, low viscosity facilitates drag reduction performance. Potassium persulfate makes the viscosity of slick water decrease sharply, which helps promote the polymer degradation and thus prevent polymer damage to the reservoir. Scanning electron microscope (SEM) showed that the drag reducer featured an obvious network structure in fresh water before gel breaking, and that there was almost no network structure but a small number of crystallites after gel breaks. In contrast, in brine, no matter before and after gel breaking, only salt crystals were cleanly seen under electron microscope due to high concentration of salt. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
24. JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12.
- Author
-
Liang, Yan, Qian, Chao, Xie, Yinghong, Huang, Xiang, Chen, Junjie, Ren, Yanlin, Fu, Ziyi, Li, Yongfei, Zeng, Tianyu, Yang, Fan, Zhou, Jianwei, Li, Wei, Yin, Yongmei, and Wang, Changqing
- Published
- 2021
- Full Text
- View/download PDF
25. Investigation of electrochromic device based on multi-step electrodeposited PB films.
- Author
-
Fu, Ziyi, Wei, Youxiu, Liu, Weiming, Li, Jiuyong, Li, Jiaming, Ma, Yibo, Zhang, Xiaofeng, and Yan, Yue
- Abstract
Prussian blue (PB) is a well-known electrochromic material due to its fast response and high cycle stability. We used the multi-step electrodeposition to prepare the PB films (S-PB) with different thickness. SEM image shows that as-grown film has small particles on its surface, which is beneficial for improving electrochromic properties of thicker PB film. The S-PB film with a thickness of 410 nm shows a high transmittance modulation of 82.04% at λ = 680 nm. S-PB and CeO
2 -TiO2 -Li films were used as working electrode and counter electrode separately to prepare electrochromic devices (ECDs), both of which are inorganic anode materials. At 680 nm wavelength, the device based on double anode materials changes transmittance from 71.25 to 11.71% and the coloration efficiency is 73.5 cm2 /C. Moreover, the optical modulation of ECD does not change significantly when performing 10,000 cycles. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
26. Synthesis of Sn-Si composite films by co-sputtering technique for high-capacity microbattery anodes.
- Author
-
Ma, Yibo, Li, Jiuyong, Wei, Youxiu, Liu, Weiming, Zhang, Xiaofeng, Fu, Ziyi, Zhang, Xuan, Peng, Jingjing, and Yan, Yue
- Abstract
Sn-Si composite anodes with linear variation composition could be synthesized by co-sputtering method directly. Ductile Sn was used as an additive material for improving the capacity and electrical conductivity of the brittle Si since the synergetic effect. The deposited films possessed a unique phase-separated structure and is beneficial to buffer the volume expansion introduced by an alloying/dealloying process, and the distributed Sn particles improved the transportation of Li
+ and remedy the inherent poor conductivity of Si. As a result, the optimal Sn-Si composite film (Sn:Si = 35.9:64.1) possessed a stable discharge capacity of 1134.0 mAh/g after two cycles and a high-capacity retention of 82.8% after 50 cycles. Si played an important role as a buffer matrix, and the increased Si content could suppress the growth of Sn grains, reduce the structural damage and enhance film adhesion. The obtained Sn-Si component film was one strong candidate for next-generation thin film anode. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
27. Risk Signature of Cancer-Associated Fibroblast–Secreted Cytokines Associates With Clinical Outcomes of Breast Cancer.
- Author
-
Sun, Chunxiao, Wang, Siwei, Zhang, Yuchen, Yang, Fan, Zeng, Tianyu, Meng, Fanchen, Yang, Mengzhu, Yang, Yiqi, Hua, Yijia, Fu, Ziyi, Li, Jun, Huang, Xiang, Wu, Hao, Yin, Yongmei, and Li, Wei
- Subjects
TREATMENT effectiveness ,CANCER prognosis ,OVERALL survival ,BREAST cancer ,CYTOKINES ,MAST cell disease ,MENARCHE - Abstract
Cancer-associated fibroblasts (CAFs) are key components in tumor microenvironment (TME). The secreted products of CAFs play important roles in regulating tumor cells and further impacting clinical prognosis. This study aims to reveal the relationship between CAF-secreted cytokines and breast cancer (BC) by constructing the risk signature. We performed three algorithms to reveal CAF-related cytokines in the TCGA BC dataset and identified five prognosis-related cytokines. Then we used single-cell RNA sequencing (ScRNA-Seq) datasets of BC to confirm the expression level of these five cytokines in CAFs. METABRIC and other independent datasets were utilized to validate the findings in further analyses. Based on the identified five-cytokine signature derived from CAFs, BC patients with high-risk score (RS) had shorter overall survival than low-RS cases. Further analysis suggested that the high-RS level correlated with cell proliferation and mast cell infiltration in BCs of the Basal-like subtype. The results also indicated that the level of RS could discriminate the high-risk BC cases harboring driver mutations (i.e., PI3KCA, CDH1, and TP53). Additionally, the status of five-cytokine signature was associated with the frequency and molecular timing of whole genome duplication (WGD) events. Intratumor heterogeneity (ITH) analysis among BC samples indicated that the high-RS level was associated with the increase of tumor subclones. This work demonstrated that the prognostic signature based on CAF-secreted cytokines was associated with clinical outcome, tumor progression, and genetic alteration. Our findings may provide insights to develop novel strategies for early intervention and prognostic prediction of BC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression.
- Author
-
Gao, Sheng, Lu, Xun, Ma, Jingjing, Zhou, Qian, Tang, RanRan, Fu, Ziyi, Wang, Fengliang, Lv, Mingming, and Lu, Cheng
- Subjects
NON-coding RNA ,LINCRNA ,BREAST cancer ,CANCER invasiveness ,MICRORNA ,OVERALL survival - Abstract
Breast cancer is one of the most common malignant tumors in women and is the second leading cause of cancer deaths among women. The tumorigenesis and progression of breast cancer are not well understood. The existing researches have indicated that non-coding RNAs, which mainly include long non-coding RNA (lncRNA) and microRNA (miRNA), have gradually become important regulators of breast cancer. We aimed to screen the differential expression of miRNA and lncRNA in the different breast cancer stages and identify the key non-coding RNA using TCGA data. Based on series test of cluster (STC) analysis, bioinformatics analysis, and negatively correlated relationships, 122 lncRNAs, 67 miRNAs, and 119 mRNAs were selected to construct the regulatory network of lncRNA and miRNA. It was shown that the miR-93/20b/106a/106b family was at the center of the regulatory network. Furthermore, 6 miRNAs, 10 lncRNAs, and 15 mRNAs were significantly associated with the overall survival (OS, log-rank P < 0.05) of patients with breast cancer. Overexpressed miR-93 in MCF-7 breast cancer cells was associated with suppressed expression of multiple lncRNAs, and these downregulated lncRNAs (MESTIT1, LOC100128164, and DNMBP-AS1) were significantly associated with poor overall survival in breast cancer patients. Therefore, the miR-93/20b/106a/106b family at the core of the regulatory network discovered by our analysis above may be extremely important for the regulation of lncRNA expression and the progression of breast cancer. The identified key miRNA and lncRNA will enhance the understanding of molecular mechanisms of breast cancer progression. Targeting these key non-coding RNA may provide new therapeutic strategies for breast cancer treatment and may prevent the progression of breast cancer from an early stage to an advanced stage. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. Association of maternal serum 25-hydroxyvitamin D concentrations with risk of preeclampsia: a nested case-control study and meta-analysis.
- Author
-
Yuan, Yingdi, Tai, Wen, Xu, Pengfei, Fu, Ziyi, Wang, Xiaolei, Long, Wei, Guo, Xirong, Ji, Chenbo, Zhang, Le, Zhang, Yue, and Wen, Juan
- Subjects
PREECLAMPSIA ,VITAMIN D deficiency ,PREGNANT women ,CASE-control method ,CHINESE people ,RESEARCH ,META-analysis ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,VITAMIN D ,COMPARATIVE studies ,SECOND trimester of pregnancy - Abstract
Objectives: Whether the maternal vitamin D deficiency is associated with preeclampsia is still an argument. We aimed to assess the association between maternal serum 25-hydroxyvitamin D [25(OH)D] concentrations and risk of preeclampsia in a Chinese population and systematically evaluate published evidence on this association.Methods: We conducted a nested case-control study involving 122 pregnant women with preeclampsia and 488 pregnant women whose blood pressure was within the normal range (as controls). For further meta-analysis, 20 studies and our study were included for the final pooled analysis, involving 39,031 participants and 3305 preeclampsia cases with various ethnicities.Results: The results showed that 65.6% of women with preeclampsia had serum 25(OH)D concentrations <50.0 nmol L-1 compared with 55.3% of women in controls. The 25(OH)D concentrations were significantly lower in women with preeclampsia than controls [Median (IQR), women with preeclampsia versus controls: 43.3 (35.5, 55.2) versus 47.5 (37.6, 60.4) nmol L-1, p = .014]. For women with 25(OH)D concentrations <50.0 nmol L-1, they had a 65% increase in preeclampsia risk (95% CI = 1.02-2.69), as compared with women with 25(OH)D concentrations from 50.0 to 74.9 nmol L-1. Further, meta-analysis showed that low 25(OH)D concentrations were associated with a significantly increased risk of preeclampsia by 62% (pooled OR = 1.62, 95%CI = 1.36-1.94), and the risk effect of low 25(OH)D concentrations existed in most subgroups.Conclusions: Low 25(OH)D concentration in pregnancy was significantly associated with preeclampsia risk, and it may serve as biomarkers for the surveillance of high-risk pregnant women. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
30. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.
- Author
-
Dai, Chencheng, Xu, Pengfei, Liu, Siyu, Xu, Sujuan, Xu, Juan, Fu, Ziyi, Cao, Jian, Lv, Mingming, Zhou, Juan, Liu, Guangquan, Zhang, Huilin, and Jia, Xuemei
- Subjects
LINCRNA ,OVARIAN epithelial cancer ,CANCER cells ,PACLITAXEL ,CISPLATIN - Abstract
Purpose: The long noncoding RNA (lncRNA) ZEB1-AS1 is reported overexpressed in sensitive ovarian cancer cells A2780 compared with paclitaxel (PTX)—and cisplatin (DDP)- resistant. However, the function and mechanism of ZEB1-AS1 in EOC cells still unknown. Methods: We used quantitative real-time PCR (qPCR) to detect ZEB1-AS1 expression in A2780 and A2780/R cells. A combination of siRNA, plasmids, CCK8 and flow cytometry was used to detect the effect of ZEB1-AS1 on ovarian cancer cell A2780 PTX and DDP resistance. Transcriptome sequencing, qPCR, and western blot were used for further mechanistic studies. Results: ZEB1-AS1 depletion using siRNA in chemosensitive A2780 cells significantly increased PTX and DDP resistance. In contrast, ZEB1-AS1 overexpression in PTX- and DDP-resistant A2780/resistant (A2780/R) cells reversed the observed drug resistance. Thus, ZEB1-AS1 plays an important role in PTX and DDP resistance in EOC cells. However, quantitative real-time PCR (qPCR) and western blot results suggested that ZEB1-AS1 did not regulate chemoresistance through regulation of ZEB1 protein. We used sequencing to detect mRNA expression changes in A2780 cells after ZEB1-AS1 silencing. The results indicated that MMP19 was the likely downstream factor of ZEB1-AS1. We further examined whether ZEB1-AS1 played an important role in chemoresistance by silencing MMP19 in ZEB1-AS1-overexpressing cells. CCK8 assay results suggested that MMP19 knockdown promoted ZEB1-AS1-induced chemoresistance to PTX and DDP in A2780 cells. Conclusion: This study is the first to reveal that ZEB1-AS1 plays a pivotal role in cancer chemoresistance. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
31. Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis.
- Author
-
Yan, Xueqi, Xie, Yinghong, Yang, Fan, Hua, Yijia, Zeng, Tianyu, Sun, Chunxiao, Yang, Mengzhu, Huang, Xiang, Wu, Hao, Fu, Ziyi, Li, Wei, Jiao, Shiping, and Yin, Yongmei
- Subjects
BREAST cancer ,RNA sequencing ,NUCLEOTIDE sequencing ,TUMOR microenvironment ,CELL morphology - Abstract
Breast cancer is a heterogeneous disease with a complex microenvironment consisting of tumor cells, immune cells, fibroblasts and vascular cells. These cancer-associated cells shape the tumor microenvironment (TME) and influence the progression of breast cancer and the therapeutic responses in patients. The exact composition of the intra-tumoral cells is mixed as the highly heterogeneous and dynamic nature of the TME. Recent advances in single-cell technologies such as single-cell DNA sequencing (scDNA-seq), single-cell RNA sequencing (scRNA-seq) and mass cytometry have provided new insights into the phenotypic and functional diversity of tumor-infiltrating cells in breast cancer. In this review, we have outlined the recent progress in single-cell characterization of breast tumor ecosystems, and summarized the phenotypic diversity of intra-tumoral cells and their potential prognostic relevance. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. Heat treatment effects in oxygen-doped β-Li3PS4 solid electrolyte prepared by wet chemistry method.
- Author
-
Li, Jiuyong, Liu, Weiming, Zhang, Xiaofeng, Ma, Yibo, Wei, Youxiu, Fu, Ziyi, Li, Jiaming, and Yan, Yue
- Subjects
SOLID state batteries ,SOLID electrolytes ,WET chemistry ,HEAT treatment ,ELECTROLYTES ,IONIC conductivity ,TREATMENT effectiveness - Abstract
For advanced all-solid-state lithium batteries, the solid electrolyte is one of the most critical components that significantly affect battery performance. Herein, solid electrolytes 75Li
2 S·(25-x)P2 S5 ·xP2 O5 (mol%) are successfully prepared via wet chemistry method. Their XRD patterns show that only the crystalline phase β-Li3 PS4 is detected for x = 0, 1, 2, 3, 5 mol% and the highest room-temperature ionic conductivity of 2.53 × 10−4 S cm−1 is obtained when x = 2. Next, effects of heat treatment on the structure and electrochemical performance of 75Li2 S·23P2 S5 ·2P2 O5 are systematically studied. The thermal stability, morphology, structure, and crystal phase of the 75Li2 S·23P2 S5 ·2P2 O5 electrolyte heated at different temperatures are characterized by thermogravimetric analysis and differential scanning calorimetry (TGA-DSC), SEM, N2 adsorption/desorption, Raman, and XRD. The 75Li2 S·23P2 S5 ·2P2 O5 electrolyte heat-treated at 320 °C exhibits the highest ionic conductivity of 2.72 × 10−4 S cm−1 , the lowest electronic conductivity of 4.8 × 10−9 S cm−1 , and excellent electrochemical stability against the metallic lithium electrode. When the heat treatment temperature further increases from 320 to 500 °C, the electrolyte partially decomposes into Li4 P2 S6 and Li2 S. Our results underscore the importance of heat treatment for the synthesis and performance optimization of solid electrolytes for the application of high-energy solid-state batteries. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
33. Relationship between tRNA‐derived fragments and human cancers.
- Author
-
Zeng, Tianyu, Hua, Yijia, Sun, Chunxiao, Zhang, Yuchen, Yang, Fan, Yang, Mengzhu, Yang, Yiqi, Li, Jun, Huang, Xiang, Wu, Hao, Fu, Ziyi, Li, Wei, and Yin, Yongmei
- Subjects
CANCER cell proliferation ,NON-coding RNA ,TRANSFER RNA ,CANCER ,GENE expression - Abstract
tRNA‐derived fragments, a class of small noncoding RNAs (sncRNAs), have been identified in numerous studies in recent years. tRNA‐derived fragments are classified into two main groups, including tRNA halves (tiRNAs) and tRNA‐derived small RNA fragments (tRFs), according to different cleavage positions of the precursor or mature tRNAs. Instead of random tRNA degradation debris, a growing body of evidence has shown that tRNA‐derived fragments are precise products of specific tRNA modifications and play important roles in biological activities, such as regulating protein translation, affecting gene expression, and altering immune signaling. Recently, the relations between tRNA‐derived fragments and the occurrence of human diseases, especially cancers, have generated wide interest. It has been demonstrated that tRNA‐derived fragments are involved in cancer cell proliferation, metastasis, progression and survival. In this review, we will describe the biogenesis of tRNA‐derived fragments, the distinct expression and function of tRNA‐derived fragments in the development of cancers, and their emerging roles as diagnostic and prognostic biomarkers and precise targets of future treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
34. Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population.
- Author
-
Yang, Fan, Huang, Xiang, Sun, Chunxiao, Li, Jianbin, Wang, Biyun, Yan, Min, Jin, Feng, Wang, Haibo, Zhang, Jin, Fu, Peifen, Zeng, Tianyu, Wang, Jian, Li, Wei, Li, Yongfei, Yang, Mengzhu, Li, Jun, Wu, Hao, Fu, Ziyi, Yin, Yongmei, and Jiang, Zefei
- Subjects
CHINESE people ,LAPATINIB ,BREAST cancer ,METASTATIC breast cancer ,PROGRESSION-free survival - Abstract
Background: The efficacy and safety of lapatinib plus capecitabine (LC or LX) versus trastuzumab plus chemotherapy in patients with HER-positive metastatic breast cancer who are resistant to trastuzumab is unknown.Methods: We retrospectively analyzed data from breast cancer patients who began treatment with regimens of lapatinib plus capecitabine (LC or LX) or trastuzumab beyond progression (TBP) at eight hospitals between May 2010 and October 2017.Results: Among 554 patients who had developed resistance to trastuzumab, the median PFS (progression free survival) was 6.77 months in the LX group compared with 5.6 months in the TBP group (hazard ratio 0.804; 95% CI, 0.67 to 0.96; P = 0.019). The central nervous system progression rate during treatment was 5.9% in the LX group and 12.5% in the TBP group (P = 0.018).Conclusion: The combination of lapatinib and capecitabine showed a prolonged PFS relative to TBP in patients who had progressed on trastuzumab. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
35. Highly robust LCL three-phase grid-connected inverter under non-ideal grid.
- Author
-
Zhang, Ziyuan, Fu, Ziyi, and Dong, Yanjie
- Published
- 2020
- Full Text
- View/download PDF
36. Serum tRNA‐derived fragments (tRFs) as potential candidates for diagnosis of nontriple negative breast cancer.
- Author
-
Huang, Yue, Ge, Han, Zheng, Mingjie, Cui, Yangyang, Fu, Ziyi, Wu, Xiaowei, Xia, Yiqin, Chen, Lie, Wang, Zhenghui, Wang, Shui, and Xie, Hui
- Subjects
BREAST cancer ,POLYMERASE chain reaction ,NEEDLE biopsy ,BREAST imaging - Abstract
Breast cancer has become the most common cancer in women, and nontriple negative breast cancer (non‐TNBC) accounts for 80–90% of all invasive breast cancers. Early detection, diagnosis, and treatment are considered key to a successful cure. Conventionally, breast imaging and needle core biopsy are used for detection and monitoring. However, small variations in volume might be ignored in imaging, and traditional biopsies are spatially and temporally limited, leading to a significant delay in cancer detection and thus prompting renewed focus on early and accurate diagnosis. In this article, we investigated whether there is an accurate molecule in peripheral blood that can help diagnose breast cancer. Similar to microRNAs, tRNA‐derived fragments (tRFs) have been reported to be involved in many pathological processes in breast cancer, but whether they can serve as candidate biomarkers for breast cancer remains unclear. Using high‐throughput sequencing technology, we identified 4,021 differentially expressed tRFs in normal and breast cancer cell lines, and eight tRFs were selected to establish a signature as a predictive biomarker of non‐TNBC. Furthermore, quantitative reverse‐transcriptase polymerase chain reaction was performed to verify the expression of the signature and analyze the correlation between dysregulated tRFs and breast cancer. The results indicated that tDR‐7816, tDR‐5334, and tDR‐4733 might be promising biomarkers. Through further bioinformatics analysis, we predicted that tDR‐7816 influences the xenobiotic metabolic processes that support the oncogenesis of breast cancer. In summary, our results provide a rationale for using circulating tDR‐7816 expression as a novel potential biomarker for the diagnosis of patients with early non‐TNBC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
37. Annealing of LiCoO2 films on flexible stainless steel for thin film lithium batteries.
- Author
-
Ma, Yibo, Chen, Mu, Yan, Yue, Wei, Youxiu, Liu, Weiming, Zhang, Xiaofeng, Li, Jiaming, Fu, Ziyi, Li, Jiuyong, and Zhang, Xuan
- Published
- 2020
- Full Text
- View/download PDF
38. Association of maternal folate status in the second trimester of pregnancy with the risk of gestational diabetes mellitus.
- Author
-
Xie, Kaipeng, Xu, Pengfei, Fu, Ziyi, Gu, Xiaohong, Li, Hui, Cui, Xianwei, You, Lianghui, Zhu, Lijun, Ji, Chenbo, and Guo, Xirong
- Subjects
SECOND trimester of pregnancy ,GESTATIONAL diabetes ,ERYTHROCYTES ,NEURAL tube defects ,ELECTRONIC health records ,BODY mass index - Abstract
Interest in the high folate status of pregnant women has increased due to its role in the prevention of neural tube defects (NTDs). The effect of increased red blood cell (RBC) folate status during the second trimester of pregnancy on gestational diabetes mellitus (GDM) remains unclear. We measured RBC folate concentrations by competitive protein‐binding assay and obtained clinical information from electronic medical records. Logistic regression analysis was used to explore the associations of RBC folate concentrations with risks of gestational diabetes mellitus (GDM). We further assessed the potential nonlinear relations between continuous log‐transformed RBC folate concentrations and GDM risk by using the restricted cubic splines. We observed high RBC folate concentrations in GDM patients compared to control group [median (interquartile range, IQR), GDM vs. controls: 1,554.03 (1,240.54–1,949.99) vs. 1,478.83 (1,124.60–1,865.71) nmol/L, p = .001]. Notably, high folate concentrations were significantly associated with an increased risk of GDM [RR per 1‐SD increase: 1.16 (1.03, 1.30), p = .012] after adjustment for maternal age, parity, and body mass index (BMI) at enrollment. In the restricted cubic spline model, a test of the null hypothesis of the linear relationship was rejected (p = .001). Our study firstly showed that maternal RBC folate concentrations during the second trimester of pregnancy increase the risk of GDM in a Chinese population. Further randomized clinical trials (RCTs) are warranted to confirm the adverse effect. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
39. Expression pattern of microRNAs related with response to trastuzumab in breast cancer.
- Author
-
Yang, Fan, Fu, Ziyi, Yang, Mengzhu, Sun, Chunxiao, Li, Yongfei, Chu, Jiahui, Zhang, Yanhong, Li, Wei, Huang, Xiang, Li, Jun, Wu, Hao, Ding, Xiaorong, and Yin, Yongmei
- Subjects
BREAST cancer ,RECEIVER operating characteristic curves ,POLYMERASE chain reaction ,PROTEIN-protein interactions ,BREAST cancer patients - Abstract
Background: Although an immense effort has been made to develop a novel biomarker for response to trastuzumab, no reliable biomarkers are available to guide management, expect for HER2. The aim of this study was to examine the relationship between microRNA (miRNA) expression and resistance to trastuzumab. Methods: Differentially expressed miRNAs between trastuzumab‐resistant and trastuzumab‐sensitive cell lines were analyzed using microarrays. We performed Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses to determine the functions of differentially expressed miRNA and their targeted genes. Furthermore, the protein–protein interactions (PPI) network was analyzed. Serum samples were collected from patients with HER2‐positive breast cancer who were treated with trastuzumab. We validated the miRNAs expression levels by quantitative reverse‐transcription polymerase chain reaction (qRT‐PCR) in these serums. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive performance of the miRNA. Results: Using miRNA microarrays, 151 miRNAs that significant differentially expressed between the trastuzumab‐resistant and sensitive cells were identified, including 46 upregulated and 105 downregulated miRNAs. Results of real‐time PCR confirmed seven miRNAs in cell lines. PI3K‐Akt signaling pathway was involved in regulating biological function according to KEGG analysis. Compared with the serums of trastuzumab‐sensitive patients, three miRNAs, namely miR‐200b, miR‐135b, and miR‐29a, were identified to be upregulated, and miR‐224 was downregulated in the trastuzumab‐resistant serums. ROC analysis showed that four miRNAs were correlated with trastuzumab resistance. Furthermore, three subnetwork modules of PPI network were obtained. Conclusion: The results indicated that miRNAs were reliable predictive biomarkers for response to trastuzumab. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
40. Proteomics analysis indicated the protein expression pattern related to the development of fetal conotruncal defects.
- Author
-
Wu, Yun, Zhang, Jingjing, Wang, Mei, Yang, Ling, Wang, Yongmei, Hu, Tao, Liu, An, Cheng, Qing, Fu, Ziyi, Zhang, Pingyang, and Cao, Li
- Subjects
PROTEIN expression ,PROTEOMICS ,FETAL development ,RNA polymerase II ,CONGENITAL heart disease ,PROTEIN analysis - Abstract
Abnormal development of embryonic conus arteriosus could lead to conotruncal defects in fetal heart, and increase the incidence of fetal congenital heart disease. Tetralogy of Fallot (TOF) is one of the most common forms of congenital heart disease. It may be helpful for us to solve this clinical problem through exploring the molecular mechanisms of development in embryonic congenital heart disease. Proteomics has attracted much attention in understanding the development of human diseases during the past decades. However, there is still little information about the relationship between protein expression pattern and TOF. In this study, we aimed to explore the potential linkage of proteomics and TOF development. Briefly, 121 differentially expressed proteins were identified from a TOF group, compared with a control group. The expression levels of 34 of these proteins were significantly different (>1.5 absolute fold change, p < 0.05) between the two groups. Gene ontology (GO) and pathway analysis showed that these proteins were mainly associated with carbon metabolism, biosynthesis of antibodies, positive regulation of transcription from RNA polymerase II promoter, nucleus, ATP binding, and so on. The ingenuity pathway analysis (IPA) results indicated that 435 of upstream regulators were identified of these differentially expressed proteins, which might be involved in the development of TOF. Data of string analysis showed the protein–protein interaction network among the differentially expressed proteins and regulators, which are related to TOF. In conclusion, our study explored the protein expression pattern of TOF, which might provide new insights into understanding the mechanism of TOF development and afford potential targets for TOF diagnosis and therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
41. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.
- Author
-
Zhang, Mi, Liu, Siyu, Fu, Chenyang, Wang, Xusu, Zhang, Min, Liu, Guangquan, Dai, Chencheng, Gong, Zhen, Xu, Hanzi, Fu, Ziyi, Xu, Pengfei, Xu, Juan, and Jia, Xuemei
- Published
- 2019
- Full Text
- View/download PDF
42. Hypoxia‐induced tRNA‐derived fragments, novel regulatory factor for doxorubicin resistance in triple‐negative breast cancer.
- Author
-
Cui, Yangyang, Huang, Yue, Wu, Xiaowei, Zheng, Mingjie, Xia, Yiqin, Fu, Ziyi, Ge, Han, Wang, Shui, and Xie, Hui
- Subjects
TRIPLE-negative breast cancer ,CANCER treatment ,NON-coding RNA ,HYPOXEMIA ,CHEMICAL resistance ,POLYMERASE chain reaction - Abstract
Triple‐negative breast cancer (TNBC) is an aggressive subtype of epithelial breast malignancy, and chemoresistance is the major obstacle for cancer therapy. TNBC is associated with a hypoxic phenotype, and hypoxia contributes to the chemoresistance in breast cancer. Transfer RNA‐derived fragments (tDRs) represent a new class of small noncoding RNAs that can be induced specifically by hypoxia. Here, we conducted a comparative analysis of the aberrant expression of tDRs in hypoxia‐treated TNBC cell lines through the use of high‐throughput sequencing technique. Quantitative real‐time polymerase chain reaction was used to validate the differently expressed tDRs between two samples. The results showed that tDR‐0009 [derived from transfer RNA (tRNA)Gly‐GCC‐1‐1] and tDR‐7336 (derived from tRNA Gly‐GCC‐1–2) were significantly upregulated when the SUM‐1315 cell lines were stimulated by hypoxia. Gene ontology (GO) and pathway analysis indicated that these two upregulated tDRs were mainly involved in maintenance of stem cell population and cellular response to interleukin (IL)‐6, which may be the underlying mechanism of hypoxia‐induced tDRs that facilitate the doxorubicin resistance in TNBC. The protein–protein interaction network for predicted target genes established by the STRING database manifested that tDR‐0009 (tDR‐7336) might be involved in the chemoresistance of TNBC via regulation of the activation of phosphorylation of STAT3. In summary, our study provided a comprehensive analysis of the deviant expression profiling of tDRs in hypoxia‐treated TNBC cell lines. Specific tDRs may be a new class of regulatory factors involved in the hypoxia‐induced chemoresistance in TNBC, and they could serve as potential biomarkers and intervention targets. Triple negative breast cancer (TNBC) is associated with a hypoxic phenotype, and hypoxia contributes to the chemoresistance in breast cancer. Transfer RNA‐derived fragments (tDRs) represent a new class of small noncoding RNAs that can be induced specifically by hypoxia. We provided a comprehensive analysis of the deviant expression profiling of tDRs in hypoxia‐treated TNBC cell lines. Specific tDRs may be a new class of regulatory factors involved in the hypoxia‐induced chemoresistance in TNBC, and they could serve as potential biomarkers and intervention targets. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
43. miRNA profiling in the hippocampus of attention‐deficit/hyperactivity disorder rats.
- Author
-
Tian, Tian, Zhang, Yan, Wu, Tianqi, Yang, Lei, Chen, Chunxiao, Li, Nan, Li, Yue, Xu, Siliang, Fu, Ziyi, Cui, Xianwei, Ji, Chenbo, Chi, Xia, Tong, Meiling, Chen, Ronghua, Hong, Qin, and Hu, Youfang
- Published
- 2019
- Full Text
- View/download PDF
44. High folate intake contributes to the risk of large for gestational age birth and obesity in male offspring.
- Author
-
Xie, Kaipeng, Fu, Ziyi, Li, Hui, Gu, Xiaohong, Cai, Zhiyong, Xu, Pengfei, Cui, Xianwei, You, Lianghui, Wang, Xing, Zhu, Lijun, Ji, Chenbo, and Guo, Xirong
- Subjects
VITAMIN B complex ,GESTATIONAL age ,PREGNANCY complications ,OBESITY ,TRIGLYCERIDES - Abstract
Folate supplementation is recommended before and during early pregnancy to prevent neural tube defects, but the effect of red blood cell (RBC) folate on large for gestational age (LGA) is still unknown. We performed a nested case‐control study including 542 LGA cases and 1,084 appropriate for gestational age (AGA) controls to examine the association of RBC folate concentrations with risk of LGA. Then, male offspring of dams fed basic folic acid (2 mg/kg, control) or 10‐fold folic acid (20 mg/kg, HFol) diet before and during pregnancy were used to explore the effect of high folate intake on birth weight and long‐term effects. We observed higher RBC folate concentrations in the cases compared to controls (p = 0.039). After adjustment for maternal age, BMI at enrollment, gestational weeks at enrollment, gestational weeks at delivery and infant gender, higher RBC folate levels were significantly associated with increased risk of LGA (Ptrend = 0.003). Interestingly, male offspring of HFol dams showed the higher birth weight, elevated levels of post loading blood glucose at 9 and 13 weeks post‐weaning and increased triglyceride (TG) and total cholesterol (TC) levels at 17 weeks post‐weaning. Furthermore, we observed that high folate intake increased the proliferation and differentiation of adipose cells. Our results suggest that maternal high folate intake confers the risk of LGA birth and accelerates the development of obesity in male offspring. Our results suggest that maternal high folate intake confers the risk of LGA birth and accelerates the development of obesity in male offspring. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
45. Systematic analysis of hsa-miR-363 gene overexpression pattern in endometrial stromal cells.
- Author
-
Li, Wenqu, Fan, Xuemei, Zhang, Mi, Huang, Lei, Lv, Shanshan, Wang, Luyu, Wu, Ying, Dai, Chencheng, Xu, Juan, Xu, Pengfei, Fu, Ziyi, Jia, Xuemei, and Shi, Xiaoyan
- Published
- 2018
- Full Text
- View/download PDF
46. Identification of tRNA‐derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple‐negative breast cancer.
- Author
-
Feng, Wanting, Li, Yongfei, Chu, Jiahui, Li, Jun, Zhang, Yanhong, Ding, Xiaorong, Fu, Ziyi, Li, Wei, Huang, Xiang, and Yin, Yongmei
- Subjects
TRIPLE-negative breast cancer ,CANCER relapse ,BIOLOGICAL tags ,NON-coding RNA ,TRANSFER RNA - Abstract
Triple‐negative breast cancer (TNBC), an intrinsic subtype of breast cancer, is characterized by aggressive pathology and shorter overall survival. Yet there is no effective therapy for these patients. Breast cancer stem cells (BCSCs) in TNBC may account for treatment failure. It is urgent to identify new therapeutic targets for TNBC. tRNA‐derived small noncoding RNAs (tDRs) represent a new class of small noncoding RNAs (sncRNA), which have been reported in some human diseases and biological processes. However, there is no detailed information about the relationship between tDRs and BCSCs. In this study, a population of CD44+/CD24−/low cells was isolated and identified by reliable BCSC surface markers. tDR expression profiles in TNBC and non‐TNBC CSCs were performed by RNA sequencing. A total of 1327 differentially expressed tDRs contained 18 upregulated and 54 downregulated in TNBC group. Furthermore, the selected tDRs were validated by quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR). tDR‐000620 expression level was consistently lower in TNBC cell lines CSCs (all P < 0.05) and serum samples (t = 2.597, P = 0.013). tDR‐000620 expression was significant association with age (P = 0.018), node status (P = 0.026) and local recurrence (P = 0.019) by chi‐square test. Kaplan‐Meier method with log‐rank test for comparison of recurrence curves. The results showed that the tDR‐000620 expression (P = 0.002) and node status (P = 0.001) group were statistically significant with recurrence‐free survival. Furthermore, multivariate Cox regression demonstrated that lymphatic metastasis (HR, 3.616; 95% CI, 1.234‐10.596; P = 0.019) and low tDR‐000620 expression (HR, 0.265; 95% CI, 0.073‐0.959; P = 0.043) were two independent adverse predictive factors for recurrence‐free survival. Finally, we found that tDR‐000620 participated in some important biological processes though GO and KEGG analysis. Taken together, our study reveals the expression profiles of tDRs in TNBC and non‐TNBC CSCs. It offers helpful information to understand the tDR‐000620 expression is responsible for the aggressive phenotype of BCSCs. It may provide predictive biomarkers and therapeutic targets for TNBC recurrence. tDR‐000620 expression is responsible for the aggressive phenotype of BCSCs. tDR‐000620 may serve as predictive biomarkers and therapeutic targets for TNBC recurrence. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
47. N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop (Adv. Sci. 23/2023).
- Author
-
Yang, Qingbin, Lei, Xuetao, He, Jiayong, Peng, Yanmei, Zhang, Yihao, Ling, Ruoyu, Wu, Chaorui, Zhang, Guofan, Zheng, Boyang, Chen, Xinhua, Zou, Boya, Fu, Ziyi, Zhao, Liying, Liu, Hao, Hu, Yanfeng, Yu, Jiang, Li, Fengping, Ye, Gengtai, and Li, Guoxin
- Subjects
STOMACH cancer ,ADDICTIONS ,GLYCOLYSIS ,NEOVASCULARIZATION inhibitors ,APATINIB - Abstract
In the cover, the angiogenesis inhibitor Apatinib (Red Armillary Sash) combined with the N acetyltransferase 10 (NAT10, Dragon Tendon) inhibitor Remodelin attenuates the hypoxia tolerance of gastric cancer cells (Dragon) and inhibits tumor progression. In article number 2300898, Fengping Li, Gengtai Ye, Guoxin Li, and co-workers demonstrate that N4-acetylcytidine (ac4C) promotes glycolysis addiction through a NAT10/SEPT9/HIF-1 I i positive feedback loop in gastric cancer cells, leading to anti-angiogenic therapy resistance. N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1 Positive Feedback Loop (Adv. Sci. 23/2023). [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
48. tRNA-Derived Fragments as Novel Predictive Biomarkers for Trastuzumab-Resistant Breast Cancer.
- Author
-
Sun, Chunxiao, Yang, Fan, Zhang, Yanhong, Chu, Jiahui, Wang, Jian, Wang, Yifan, Zhang, Yanqiu, Li, Jun, Li, Yongfei, Fan, Ruihua, Li, Wei, Huang, Xiang, Wu, Hao, Fu, Ziyi, Jiang, Zefei, and Yin, Yongmei
- Subjects
MICRORNA ,BREAST cancer ,BIOMARKERS ,TRASTUZUMAB ,CANCER treatment - Abstract
Background/Aims: Resistance to trastuzumab remains a common challenge to HER-2 positive breast cancer. Up until now, the underlying mechanism of trastuzumab resistance is still unclear. tRNA-derived small non-coding RNAs, a new class of small non-coding RNA (sncRNAs), have been observed to play an important role in cancer progression. However, the relationship between tRNA-derived fragments and trastuzumab resistance is still unknown.Methods: We detected the levels of tRNA-derived fragments expression in normal breast epithelial cell lines, trastuzumab-sensitive and -resistant breast cancer cell lines using high-throughput sequencing. qRT-PCR was conducted to validate the differentially expressed fragments in serums from trastuzumab-sensitive and -resistant patients. A receiver operating characteristic (ROC) curve analysis was performed to evaluate the power of specific tRNA-derived fragments. Progression-free survival (PFS) was analyzed using Cox-regression.Results: Our sequence results showed that tRNA-derived fragments were differentially expressed in the HBL-100, SKBR3, and JIMT-1 cell lines. tRF-30-JZOYJE22RR33 and tRF-27-ZDXPHO53KSN were found significantly upregulated in trastuzumab-resistant patients compared to sensitive individuals, and the ROC analysis showed that tRF-30-JZOYJE22RR33 and tRF-27-ZDXPHO53KSN were correlated with trastuzumab resistance. In a multivariate analysis, higher levels of tRF-30-JZOYJE22RR33 and tRF-27-ZDXPHO53KSN expression were associated with significantly shorter PFS in patients with metastatic HER-2 positive breast cancer.Conclusion: Our results suggest that tRF-30-JZOYJE22RR33 and tRF-27-ZDXPHO53KSN play important roles in trastuzumab resistance. Patients with high levels of tRF-30-JZOYJE22RR33 and tRF-27-ZDXPHO53KSN expression benefitted less from trastuzumab-based therapy than those that express lower-levels of these molecules. tRF-30-JZOYJE22RR33 and tRF-27-ZDXPHO53KSN may be potential biomarkers and intervention targets in the clinical treatment of trastuzumab-resistant breast cancer. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
49. MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells.
- Author
-
Chu, Jiahui, Li, Yongfei, Fan, Xuemei, Ma, Jingjing, Li, Jun, Lu, Guangping, Zhang, Yanhong, Huang, Yi, Li, Wei, Huang, Xiang, Fu, Ziyi, Yin, Yongmei, and Yuan, Hongyan
- Subjects
MICRORNA ,TRIPLE-negative breast cancer ,CANCER stem cells ,CARCINOGENESIS ,METASTASIS ,STEM cell treatment - Abstract
Background/Aims: High levels of cancer stem cells (CSCs) in patients with triple-negative breast cancer (TNBC) correlate with risk of poor clinical outcome and possibly contribute to chemoresistance and metastasis in patients with highly malignant TNBC. Aberrant microRNA expression is associated with the dysfunction of self-renewal and proliferation in cancer stem cells, while there is little information about the TNBC-specific microRNAs in regulating CSC ability.Methods: Solexa deep sequencing was performed to detect the expression levels of TNBC or non-TNBC stem cells (CSCs) microRNAs. Mammosphere formation assay, qRT-PCR and the xenograft model in nude mice were performed. Bioinformatic analysis and microarray were used to select the target gene, and luciferase reporter assays were used to confirm the binding sites.Results: Solexa sequencing data exhibited differential expression of 193 microRNAs between TNBC and non-TNBC stem cells. The gene ontology analysis and pathways analyses showed that genes were involved in the maintenance of stemness. MiR-4319 could suppress the self-renewal and formation of tumorspheres in TNBC CSCs through E2F2, and also inhibited tumor initiation and metastasis in vivo. Moreover, increased E2F2 could reverse the effect of miR-4319 on the self-renewal in TNBC CSCs.Conclusions: MiR-4319 suppresses the malignancy of TNBC by regulating self-renewal and tumorigenesis of stem cells and might be a remarkable prognostic factor or therapeutic target for patients with TNBC. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
50. Cancer/testis antigen‐Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway.
- Author
-
Li, Yongfei, Chu, Jiahui, Li, Jun, Feng, Wanting, Yang, Fan, Wang, Yifan, Zhang, Yanhong, Sun, Chunxiao, Yang, Mengzhu, Vasilatos, Shauna N., Huang, Yi, Fu, Ziyi, and Yin, Yongmei
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.